Serving leading biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving leading biopharmaceutical companies globally:
Generated: October 16, 2017
Which drugs does patent 7,918,823 protect, and when does it expire?
| Title: | Devices, systems and methods for medicament delivery |
| Abstract: | Apparatuses for automatic medicament injection and methods for manufacturing automatic medicament injectors are described herein. In some embodiments, an apparatus includes a housing, a needle, an energy storage member, an actuator, a locking member, and a needle guard. The needle is configured to move between a first position and a second position. In its first position, the needle is contained within the housing. In its second position, at least a portion of the needle extends from the housing. The energy storage member has a first configuration and a second configuration and is configured to produce a force when moving between its first configuration and its second configuration to move the needle from its first position to its second position. The actuator is configured to move the energy storage member from its first configuration to its second configuration. The locking member is movably coupled to the distal end portion of the housing such that the locking member can be moved between a first position and a second position. In its first position, the locking member is configured to engage the actuator to prevent the actuator from moving the energy storage member to the second configuration. The needle guard is removably coupled to at least one of the distal end portion of the housing or a base movably coupled to the distal end portion of the housing. |
| Inventor(s): | Edwards; Eric Shawn (Midlothian, VA), Edwards; Evan Thomas (Fredericksburg, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN) |
| Assignee: | Intelliject, Inc. (Richmond, VA) |
| Application Number: | 12/688,314 |
|
Patent Claim Types: see list of patent claims | Device; Dosage form; |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kaleo Inc | AUVI-Q | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 201739-002 | Aug 10, 2012 | BX | RX | Yes | Yes | ► Subscribe | ► Subscribe | Y | |||
Kaleo Inc | AUVI-Q | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 201739-001 | Aug 10, 2012 | BX | RX | Yes | No | ► Subscribe | ► Subscribe | Y | |||
Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | RX | Yes | Yes | ► Subscribe | ► Subscribe | Y | ||||
Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | ► Subscribe | ► Subscribe | Y | ||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8,932,252 | Medical injector simulation device | ► Subscribe | |||||||||||||
| 7,731,690 | Devices, systems and methods for medicament delivery | ► Subscribe | |||||||||||||
| 9,149,579 | Devices, systems and methods for medicament delivery | ► Subscribe | |||||||||||||
| 8,361,026 | Apparatus and methods for self-administration of vaccines and other medicaments | ► Subscribe | |||||||||||||
| 8,231,573 | Medicament delivery device having an electronic circuit system | ► Subscribe | |||||||||||||
| 8,206,360 | Devices, systems and methods for medicament delivery | ► Subscribe | |||||||||||||
| 8,425,462 | Devices, systems, and methods for medicament delivery | ► Subscribe | |||||||||||||
| 7,416,540 | Devices systems and methods for medicament delivery | ► Subscribe | |||||||||||||
| 9,555,191 | Apparatus and methods for self-administration of vaccines and other medicaments | ► Subscribe | |||||||||||||
| 8,016,788 | Devices, systems and methods for medicament delivery | ► Subscribe | |||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia | 2004325202 | ► Subscribe | |||||||||||||
| Australia | 2006210865 | ► Subscribe | |||||||||||||
| Australia | 2007245139 | ► Subscribe | |||||||||||||
| Australia | 2009200841 | ► Subscribe | |||||||||||||
| Australia | 2009246525 | ► Subscribe | |||||||||||||
| Australia | 2012201481 | ► Subscribe | |||||||||||||
| Australia | 2015264857 | ► Subscribe | |||||||||||||
| Canada | 2586525 | ► Subscribe | |||||||||||||
| Canada | 2594627 | ► Subscribe | |||||||||||||
| Canada | 2644547 | ► Subscribe | |||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,910 others who get our Drug Patent Expiration Alerts:
